Related Experiment Videos

Protection of research subjects

The New England Journal of Medicine

|July 15, 2003

Abstract

No abstract available in PubMed .

Keywords:

Biomedical and Behavioral Research

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Pilot phase II study of the combination of lenvatinib (L) and eribulin (E) in advanced solid tumors.

International journal of cancer·2025

First-Line Combination of R-CHOP with the PDE4 Inhibitor Roflumilast for High-Risk DLBCL.

Cancers·2024

Gemcitabine resistance of pancreatic cancer cells is mediated by IGF1R dependent upregulation of CD44 expression and isoform switching.

Cell death & disease·2022

Camidanlumab tesirine in patients with relapsed or refractory lymphoma: a phase 1, open-label, multicentre, dose-escalation, dose-expansion study.

The Lancet. Haematology·2021

Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2018

The biology and role of CD44 in cancer progression: therapeutic implications.

Journal of hematology & oncology·2018

See all related articles